A Phase Ib/II Trial of Ipilimumab-Nivolumab-Denosumab and Nivolumab-Denosumab in Patients with Unresectable Stage III and IV Melanoma (CHARLI Study).
- Shackleton, Mark (Primary Chief Investigator (PCI))
- Hawkins, Cheryl-Ann (Project Manager)
Project: Research